Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 28, 2025
Reporting Period: Single event date (August 28, 2025)
This filing serves as a Regulation FD disclosure to announce upcoming investor relations events. It does not cover a financial reporting period (e.g., quarterly or annual) and contains no audited financial statements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is an event notification and does not include financial performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces scheduled corporate presentations.
Guidance, Outlook, and Management Commentary
Upcoming Events:
- Wells Fargo Healthcare Conference: Fireside chat with Jasbir Seehra, President and CEO, on September 4, 2025, at 2:15 p.m. Eastern time.
- H.C. Wainwright 27th Annual Global Investment Conference: Corporate presentation on September 9, 2025, at 12:00 p.m. Eastern time.
Legal Disclaimer: The information furnished in this report and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the upcoming presentations at the Wells Fargo and H.C. Wainwright conferences.
- Review the full text of the press release (Exhibit 99.1) for any additional details on the presentation topics.
- Check subsequent filings (e.g., 10-Q or 10-K) for actual financial metrics, as this 8-K contains none.
- Confirm the trading symbol (KROS) on The Nasdaq Stock Market LLC.